ARTV - SEC Form 4 insider transactions

SEC Form 4 filed by Artiva Biotherapeutics Inc.

SEC Form 4 filed by Artiva Biotherapeutics Inc.

SEC Form 4 filed by Artiva Biotherapeutics Inc.

SEC Form 4 filed by Artiva Biotherapeutics Inc.

SEC Form 4 filed by Artiva Biotherapeutics Inc.

Chief Executive Officer Aslan Fred was granted 110,000 shares, increasing direct ownership by 7% to 1,604,765 units (SEC Form 4)

Chief Executive Officer Aslan Fred was granted 45,000 shares, increasing direct ownership by 3% to 1,494,765 units (SEC Form 4)

SEC Form 4 filed by Director Ra Capital Management, L.P.

SEC Form 4 filed by Director Stoppel Laura

SEC Form 4 filed by Director Hougen Elizabeth L

SEC Form 4 filed by Director Sorg Elaine K.

SEC Form 4 filed by Director Daniels Brian

SEC Form 4 filed by Director Baker Daniel G.

SEC Form 4 filed by Director Moore Alison

President & Head of R&D Miralles Gines Diego was granted 45,000 shares, increasing direct ownership by 58% to 122,500 units (SEC Form 4)

Chief Tech Operations Officer Horan Christopher was granted 40,000 shares, increasing direct ownership by 14% to 323,084 units (SEC Form 4)

COO, CLO, Compliance Officer Bush Jennifer was granted 45,000 shares, increasing direct ownership by 14% to 374,529 units (SEC Form 4)

Chief Medical Officer Banerjee Subhashis was granted 30,000 shares, increasing direct ownership by 21% to 170,947 units (SEC Form 4)

Chief Executive Officer Aslan Fred sold $255,746 worth of shares (23,429 units at $10.92) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 1,449,765 units (SEC Form 4)

SEC Form 4 filed by Director Ra Capital Management, L.P.

SEC Form 4 filed by Director Stoppel Laura

SEC Form 4 filed by Director Sorg Elaine K.

SEC Form 4 filed by Director Hougen Elizabeth L

SEC Form 4 filed by Director Daniels Brian

SEC Form 4 filed by Director Baker Daniel G.

SEC Form 4 filed by Director Moore Alison

Chief Tech Operations Officer Horan Christopher sold $115,638 worth of shares (10,366 units at $11.16), decreasing direct ownership by 4% to 283,084 units (SEC Form 4) (for withholding tax)

COO, CLO, Compliance Officer Bush Jennifer sold $93,606 worth of shares (8,391 units at $11.16), decreasing direct ownership by 2% to 329,529 units (SEC Form 4) (tax liability)

Chief Medical Officer Banerjee Subhashis sold $12,271 worth of shares (1,100 units at $11.16), decreasing direct ownership by 0.77% to 140,947 units (SEC Form 4) to cover taxes

Chief Executive Officer Aslan Fred sold $690,392 worth of shares (61,888 units at $11.16), decreasing direct ownership by 4% to 1,473,194 units (SEC Form 4) (tax liability)

Chief Medical Officer Banerjee Subhashis exercised 5,306 shares at a strike of $1.92 and sold $98,736 worth of shares (8,222 units at $12.01) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 142,047 units (SEC Form 4)

Chief Medical Officer Banerjee Subhashis exercised 429 shares at a strike of $1.92 and sold $5,148 worth of shares (429 units at $12.00) as part of a pre-agreed trading plan (SEC Form 4)

SVP, Research and Development Raymon Heather sold $27,879 worth of shares (3,095 units at $9.01), decreasing direct ownership by 2% to 148,228 units (SEC Form 4) to satisfy withholding tax

Chief Tech Operations Officer Horan Christopher sold $63,073 worth of shares (7,002 units at $9.01), decreasing direct ownership by 2% to 293,450 units (SEC Form 4) (for withholding tax)

COO, CLO, Compliance Officer Bush Jennifer sold $79,179 worth of shares (8,790 units at $9.01), decreasing direct ownership by 3% to 337,920 units (SEC Form 4) (tax liability)

Chief Medical Officer Banerjee Subhashis sold $63,386 worth of shares (7,037 units at $9.01), decreasing direct ownership by 5% to 144,963 units (SEC Form 4) to cover withholding tax

Chief Executive Officer Aslan Fred sold $244,253 worth of shares (27,116 units at $9.01), decreasing direct ownership by 2% to 1,535,082 units (SEC Form 4) (withholding tax)

President & Head of R&D Miralles Gines Diego was granted 77,500 shares (SEC Form 4)

Chief Financial Officer Huston Thad Allen was granted 220,000 shares (SEC Form 4)

SEC Form 4 filed by Director Sorg Elaine K.

SVP, Research and Development Raymon Heather was granted 46,000 shares and covered exercise/tax liability with 1,521 shares, increasing direct ownership by 42% to 151,323 units (SEC Form 4)

Chief Tech Operations Officer Horan Christopher was granted 117,300 shares and covered exercise/tax liability with 2,187 shares, increasing direct ownership by 62% to 300,452 units (SEC Form 4)

COO, CLO, Secy, Compliance Off Bush Jennifer covered exercise/tax liability with 3,515 shares and was granted 117,300 shares, increasing direct ownership by 49% to 346,710 units (SEC Form 4)

Chief Medical Officer Banerjee Subhashis was granted 102,000 shares, increasing direct ownership by 204% to 152,000 units (SEC Form 4)

President and CEO Aslan Fred was granted 366,850 shares and covered exercise/tax liability with 14,600 shares, increasing direct ownership by 29% to 1,562,198 units (SEC Form 4)

President and CEO Aslan Fred sold $19,122 worth of shares (3,187 units at $6.00), decreasing direct ownership by 0.26% to 1,209,948 units (SEC Form 4)

SVP, Research and Development Raymon Heather was granted 67,253 shares, increasing direct ownership by 170% to 106,844 units (SEC Form 4)

Chief Tech Operations Officer Horan Christopher was granted 107,156 shares, increasing direct ownership by 137% to 185,339 units (SEC Form 4)

COO, CLO, Secy, Compliance Off Bush Jennifer was granted 84,877 shares, increasing direct ownership by 57% to 232,925 units (SEC Form 4)

President and CEO Aslan Fred was granted 869,136 shares, increasing direct ownership by 253% to 1,213,135 units (SEC Form 4)

SVP, Research and Development Raymon Heather covered exercise/tax liability with 1,375 shares, decreasing direct ownership by 3% to 39,591 units (SEC Form 4)

Chief Tech Operations Officer Horan Christopher covered exercise/tax liability with 1,899 shares, decreasing direct ownership by 2% to 78,183 units (SEC Form 4)

COO, CLO, Secy, Compliance Off Bush Jennifer covered exercise/tax liability with 3,055 shares, decreasing direct ownership by 2% to 148,048 units (SEC Form 4)

Chief Financial Officer Krishnamohan Neha covered exercise/tax liability with 3,490 shares, decreasing direct ownership by 3% to 99,356 units (SEC Form 4)

President and CEO Aslan Fred sold $21,522 worth of shares (6,375 units at $3.38) and covered exercise/tax liability with 6,347 shares, decreasing direct ownership by 4% to 343,999 units (SEC Form 4)

President and CEO Aslan Fred sold $153,000 worth of shares (25,500 units at $6.00), decreasing direct ownership by 7% to 356,721 units (SEC Form 4)

Chief Financial Officer Krishnamohan Neha covered exercise/tax liability with 7,154 shares, decreasing direct ownership by 7% to 102,846 units (SEC Form 4)

President and CEO Aslan Fred covered exercise/tax liability with 8,944 shares and sold $69,579 worth of shares (25,500 units at $2.73), decreasing direct ownership by 8% to 382,221 units (SEC Form 4)

SVP, Research and Development Raymon Heather covered exercise/tax liability with 2,384 shares, decreasing direct ownership by 5% to 40,966 units (SEC Form 4)

Chief Tech Operations Officer Horan Christopher covered exercise/tax liability with 4,918 shares, decreasing direct ownership by 6% to 80,082 units (SEC Form 4)